Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Ehninger

Showing results (151-160 of 403) with videos related to

Pageof 41
Sort By:
Case Reports in Oncological Medicine|August 13, 2013
PET/MRI Imaging in High-Risk Sarcoma: First Findings and Solving Clinical ProblemsMarkus K Schuler, Stephan Richter, Bettina Beuthien-Baumann, et al.
British Journal of Haematology|March 22, 2003
Successful combination of anti-CD33 antibody (gemtuzumab ozogamicin) and minimal conditioning before second allografting in recurrent acute myeloid leukaemiaMathias Hänel, Christian Thiede, Anett Helwig, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 2005
Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cellsJana Babatz, Christoph Röllig, Bärbel Löbel, et al.
Blood|December 7, 2007
MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patientsHannes Wandt, Ulrike Schäkel, Frank Kroschinsky, et al.
The Journal of Clinical Endocrinology and Metabolism|December 9, 2004
Prevalence of HLA-DRB1 genotype and altered Fas/Fas ligand expression in adrenocortical carcinomaGernot W Wolkersdörfer, Christian Marx, John Brown, et al.
Haematologica|October 29, 2017
Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathwayEkaterina Balaian, Manja Wobus, Heike Weidner, et al.
Oncoimmunology|July 22, 2021
Evaluation of switch-mediated costimulation in trans on universal CAR-T cells (UniCAR) targeting CD123-positive AMLJan-Erik Meyer, Simon Loff, Josephine Dietrich, et al.
Leukemia|June 22, 2018
Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic associationClaudia Gebhard, Dagmar Glatz, Lucia Schwarzfischer, et al.
Experimental Hematology|June 19, 2012
Impact of lenalidomide on the functional properties of human mesenchymal stromal cellsManja Wobus, Gwendolin Benath, Ruben A Ferrer, et al.
Haematologica|August 6, 2002
Intensified double induction therapy with high dose mitoxantrone, etoposide, m-amsacrine and high dose ara-C for elderly acute myeloid leukemia patients aged 61-65 yearsMarkus Schaich, Thomas Illmer, Walter Aulitzky, et al.
Pageof 41

Showing results (151-160 of 403) with videos related to

Sort By:
Pageof 41
Case Reports in Oncological Medicine|August 13, 2013
PET/MRI Imaging in High-Risk Sarcoma: First Findings and Solving Clinical ProblemsMarkus K Schuler, Stephan Richter, Bettina Beuthien-Baumann, et al.
British Journal of Haematology|March 22, 2003
Successful combination of anti-CD33 antibody (gemtuzumab ozogamicin) and minimal conditioning before second allografting in recurrent acute myeloid leukaemiaMathias Hänel, Christian Thiede, Anett Helwig, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 2005
Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cellsJana Babatz, Christoph Röllig, Bärbel Löbel, et al.
Blood|December 7, 2007
MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patientsHannes Wandt, Ulrike Schäkel, Frank Kroschinsky, et al.
The Journal of Clinical Endocrinology and Metabolism|December 9, 2004
Prevalence of HLA-DRB1 genotype and altered Fas/Fas ligand expression in adrenocortical carcinomaGernot W Wolkersdörfer, Christian Marx, John Brown, et al.
Haematologica|October 29, 2017
Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathwayEkaterina Balaian, Manja Wobus, Heike Weidner, et al.
Oncoimmunology|July 22, 2021
Evaluation of switch-mediated costimulation in trans on universal CAR-T cells (UniCAR) targeting CD123-positive AMLJan-Erik Meyer, Simon Loff, Josephine Dietrich, et al.
Leukemia|June 22, 2018
Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic associationClaudia Gebhard, Dagmar Glatz, Lucia Schwarzfischer, et al.
Experimental Hematology|June 19, 2012
Impact of lenalidomide on the functional properties of human mesenchymal stromal cellsManja Wobus, Gwendolin Benath, Ruben A Ferrer, et al.
Haematologica|August 6, 2002
Intensified double induction therapy with high dose mitoxantrone, etoposide, m-amsacrine and high dose ara-C for elderly acute myeloid leukemia patients aged 61-65 yearsMarkus Schaich, Thomas Illmer, Walter Aulitzky, et al.
Pageof 41